In Re: 18-12425-mg Aralez Pharmaceuticals US Inc., et al.

Memorandum Opinion, signed on 11/19/2018, Granting Debtor's Motion for Order Authorizing Implementation of Key Executive Incentive Plan. (related document(s)259, 253, 283)

File: